Publications by authors named "K Zargar-Shoshtari"
Article Synopsis
- The study aimed to evaluate how PSA testing rates impact prostate cancer diagnosis and mortality in Māori men in New Zealand.
- Over 63,000 Māori men were analyzed, revealing higher prostate cancer diagnosis and better survival rates among those who underwent regular PSA testing compared to those who did not.
- The findings suggest that increased frequency of PSA testing could significantly enhance cancer survival rates in Māori men, indicating a need for prioritizing regular testing in this population.
Background: Prostate cancer is now the most common cancer in men in Australia. Men should be aware of the potential risk of significant prostate cancer despite the lack of symptoms. Screening for prostate cancer using prostate-specific antigen (PSA) has been controversial.
View Article and Find Full Text PDFProstate cancer (PCa) is a significant healthcare problem worldwide. Current diagnosis and treatment methods are limited by a lack of precise in vivo tissue analysis methods. Real-time cancer identification and grading could dramatically improve current protocols.
View Article and Find Full Text PDFMulticenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol
November 2022
Purpose: Cisplatin-based chemotherapy followed by radical cystectomy (RC) is recommended in patients with muscle-invasive bladder cancer (MIBC). However, up to 50% of patients are cisplatin ineligible. The aim of this study was to compare clinical outcomes after ≥ 3 cycles of preoperative gemcitabine-carboplatin (gem-carbo) versus gemcitabine-cisplatin (gem-cis).
View Article and Find Full Text PDF